Nancy Hutson, PhD

Nancy has served as a member of PhaseBio’s board of directors since March 2018. She has more than 30 years of experience in the pharmaceutical industry. She retired from Pfizer Inc. in 2006 after spending 25 years in research and leadership positions, most recently serving as Senior Vice President of Global Research & Development and director of Pfizer’s pharmaceutical research and development site Groton / New London Laboratories. Nancy currently serves on the boards of directors for BioCryst Pharmaceuticals, Inc., Endo International plc and Clearside Biomedical, Inc. She received a BA in general biology from Illinois Wesleyan University and a PhD in physiology and biochemistry from Vanderbilt University.